INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹70 Cr | ₹56 Cr | ₹48 Cr | ₹35 Cr | ₹20 Cr |
What is the latest Net Current Assets ratio of INDO US BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹70 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹20 Cr |
How is Net Current Assets of INDO US BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | 26.54 | |
| Mar2024 | ₹56 Cr | 16.82 | |
| Mar2023 | ₹48 Cr | 36.64 | |
| Mar2022 | ₹35 Cr | 72.77 | |
| Mar2021 | ₹20 Cr | - | |
Compare Net Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹282.2 Cr | -6.7% | 6.9% | -35% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,047.9 Cr | -2.7% | 0.8% | -7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,107.4 Cr | -1.7% | -7.4% | -20.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,910.0 Cr | -1.5% | -10.6% | -18.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹931.3 Cr | -3.7% | -1.7% | -36% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹362.5 Cr | -5.6% | -13.7% | -20.2% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -6.7% |
6.9% |
-35% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses